SHG:688399 - Jiangsu Bioperfectus Technologies Co Ltd

Jiangsu Bioperfectus Technolog
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance (Live Price)

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2016 Q4	2017 Q4	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0% -	-	0% -	52.69% -	50.34% -4.5%	49.71% -1.3%	48.5% -2.4%	48.5% 0%	48.5% 0%	45.69% -5.8%	45.69% 0%	-
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	44.13% -4.2%	43.9% -0.5%	42.03% -4.3%	41% -2.4%	38.69% -5.6%	36.72% -5.1%	33.03% -10.1%	28.67% -13.2%	21.42% -25.3%	1.81% -91.5%	-92.72% -	-78.53% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	74.08% -1.6%	71.74% -3.2%	69.13% -3.6%	65.74% -4.9%	62.35% -5.2%	60.63% -2.8%	60.62% 0.0%	59.53% -1.8%	61.23% 2.9%	60.39% -1.4%	63.91% 5.8%	65.21% 2.0%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	50.73% -5.2%	50.94% 0.4%	47.83% -6.1%	47% -1.7%	45.18% -3.9%	43.26% -4.2%	44.45% 2.8%	41.11% -7.5%	38.02% -7.5%	23.43% -38.4%	-53.2% -	-40.73% -
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.3B -4.1%	2.81B 22.3%	2.84B 1.0%	3.5B 23.4%	4.97B 41.9%	4.96B -0.3%	5.53B 11.6%	4.11B -25.8%	2.46B -40.2%	1.52B -38.2%	403.18M -73.4%	400.25M -0.7%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.39B -9.7%	3.06B 28.1%	3.5B 14.2%	4.41B 25.9%	4.48B 1.6%	4.65B 3.9%	4.89B 5.2%	4.72B -3.6%	4.35B -7.8%	4.29B -1.5%	3.91B -8.9%	4.03B 3.2%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	548.32M -8.4%	725.69M 32.3%	962.89M 32.7%	1.24B 28.5%	1.29B 4.5%	1.08B -16.8%	1.11B 3.4%	956.71M -14.0%	639.08M -33.2%	683.21M 6.9%	501.31M -26.6%	588.08M 17.3%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.84B -10.1%	2.34B 26.8%	2.54B 8.5%	3.17B 24.9%	3.18B 0.5%	3.57B 12.3%	3.78B 5.7%	3.76B -0.5%	3.71B -1.3%	3.6B -2.9%	3.41B -5.5%	3.45B 1.2%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	708.47M -	-	985.52M -	-	1.81B -	-	1.96B -	-	723.83M -	-	-113.14M -	-
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	156M 66.7%	242.36M 55.4%	646.13M 166.6%	535.56M -17.1%	400.82M -25.2%	566.11M 41.2%	647.48M 14.4%	1.06B 64.0%	929.45M -12.5%	1.1B 18.7%	1.23B 11.3%	979.64M -20.2%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	403.57M -24.8%	568.41M 40.8%	647.48M 13.9%	1.06B 64.3%	928.45M -12.7%	1.1B 18.3%	1.23B 11.8%	978.8M -20.3%	568.27M -41.9%	676.44M 19.0%	1.63B 141.1%	2.16B 32.2%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	486.07M -32.0%	768.52M 58.1%	681.91M -11.3%	1.04B 52.5%	1.43B 37.4%	1.39B -3.1%	1.61B 16.5%	1.01B -37.1%	536.75M -47.1%	227.73M -57.6%	-224.48M -	77.58M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.01B -	-	1.19B -	-	1.92B -	-	1.83B -	-	526.08M -	-	-373.81M -	-
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	17.29 -8.1%	21.04 21.7%	20.36 -3.2%	24.52 20.4%	32.84 33.9%	31.08 -5.4%	31.18 0.3%	20.08 -35.6%	8.97 -55.3%	0.47 -94.8%	-6.38 -	-5.37 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	65.74% -5.4%	65.55% -0.3%	56.81% -13.3%	55.06% -3.1%	76.56% 39.1%	61.61% -19.5%	57.89% -6.0%	34% -41.3%	15.26% -55.1%	0.77% -95.0%	-10.41% -	-8.73% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	51.31% -7.7%	49.91% -2.7%	41.31% -17.2%	40.73% -1.4%	56.04% 37.6%	47.22% -15.7%	43.57% -7.7%	25.82% -40.7%	11.92% -53.8%	0.62% -94.8%	-8.5% -	-7.19% -